The trial achieved its primary endpoint, showing a statistically significant reduction in Valsalva LVOT gradient at week 28.

Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.

The partnership aims to deploy AI capabilities that automatically analyse X-ray and CT images to assist radiologists.

Bristol Myers Squibb’s oncology-focused campaign was developed in partnership with 2025 MM+M Agency 100 honoree Real ...

Automotive BMS must undergo rigorous testing to verify that it meets stringent performance and safety standards. BMS emulation involves using hardware and software tools to simulate the behavior of a ...

After scoring in a more common form of pulmonary fibrosis in May, Bristol Myers Squibb’s lysophosphatidic acid receptor 1 (LPA1) antagonist has turned out positive results in a rarer incarnation of ...

This deal marks another addition to BMS’s growing pipeline, which the company hopes will stave off the impacts of the upcoming patent cliff.

The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless battery-management systems introduce a new way to cover all of these needs. What’s the ...

BMS is focusing on a diversified portfolio to stabilize and grow revenues post-loss-of-exclusivity, avoiding reliance on a single blockbuster. Pipeline execution in oncology, cardiovascular, and ...